健喬信元醫藥生技股份有限公司 2025 Sustainability Report

Report summary

• This page summarizes the 2025 sustainability report and ESG report PDF source for 健喬信元醫藥生技股份有限公司 (4114).
• The reporting period is 2025/01/01 to 2025/12/31, in the 生技醫療業 industry.
• third-party information includes assurance body 國富浩華聯合會計師事務所; this can be used to review report verification, assurance, and disclosure standards.
• Compare public disclosure approaches across prior-year and peer reports. Your company’s actual disclosures must still be based on its own data and supporting evidence.

Report details

Company

健喬信元醫藥生技股份有限公司（4114）

Reporting Year

2025

Disclosure Period

2025/01/01 to 2025/12/31

Industry

生技醫療業

Third-party information

third-party information includes assurance body 國富浩華聯合會計師事務所

PDF source

The original ESG report PDF can be downloaded or opened from this page

2025 ESG Metrics and Industry Comparison

Greenhouse Gas Emissions

Scope 1 Emissions (Tons CO2e)

3,336

Reporting Boundary：已完成合併財務報表之母子公司

Verification：否

Scope 2 Emissions (Tons CO2e)

12,961

Reporting Boundary：已完成合併財務報表之母子公司

Verification：否

Scope 3 Emissions (Tons CO2e)

Not disclosed

Reporting Boundary：Not disclosed

Verification：否

Energy Management

Renewable Energy Share

Not disclosed

Reporting Boundary：健喬信元總公司、健喬廠、健康廠、七星廠、優良廠、光復廠

Verification：Not disclosed

Water Management

Water Use (Metric Tons)

180,235

Reporting Boundary：健喬信元總公司、健喬廠、健康廠、七星廠、優良廠、光復廠

Verification：Not disclosed

Board of Directors

Board Seats (Including Independent Directors)

9

Independent Director Seats

4

Female Director Ratio

33.3%

Ranked 25 among 96 companies in the same industry (percentile 69).

Board Meeting Attendance Rate

96.9%

Ranked 51 among 96 companies in the same industry (percentile 47).

Independent Director Ratio

44.4%

Ranked 30 among 96 companies in the same industry (percentile 60).

Source: Taiwan Stock Exchange / Taipei Exchange, Corporate ESG Disclosure Summary (2025), under the Open Government Data License, version 1.0. Open Government Data License, Version 1.0

How to use this report

• Compare how 健喬信元醫藥生技股份有限公司 structured 生技醫療業 sustainability report chapters and material topics in 2025.
• Confirm the reporting period, third-party verification or assurance information, and downloadable ESG report PDF source.
• Mark public disclosures and original page numbers that can be referenced as research materials for planning chapters and indicators for your own company.